Clinical Trial Update: Efficacy and Tolerability of ILY101 in Dialysis Patients With Hyperphosphatemia [Phase 2]

View source ↗

Summary

Phase 2 trial update assessing the efficacy and tolerability of ILY101 in dialysis patients with hyperphosphatemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• ILY101

Snippet

Sponsor: Ilypsa | Conditions: Kidney Diseases, Renal Insufficiency | Phase 2 | Status: UNKNOWN